Pieragostini R - Search Results

1

[Assessment of the impact of pharmaceutical consultations at initiation of a treatment with emicizumab in patients with severe hemophilia A without inhibitors].

Nasr Allah M, Pieragostini R, Oka G, Batista R, Stieltjes N, Lopez I. Nasr Allah M, et al. Among authors: pieragostini r. Ann Pharm Fr. 2022 Nov;80(6):915-922. doi: 10.1016/j.pharma.2022.02.003. Epub 2022 Feb 10. Ann Pharm Fr. 2022. PMID: 35151626 French.

2

[A check-list in order to optimise the deployment of computerized medicine cabinets in a hospital: An essential support].

Pieragostini R, Le Corre B, Poupon V, Garnier A, Madelaine I, Deville L. Pieragostini R, et al. Ann Pharm Fr. 2022 Jul;80(4):570-575. doi: 10.1016/j.pharma.2021.09.001. Epub 2021 Sep 22. Ann Pharm Fr. 2022. PMID: 34560066 French.

3

[Subcontracting a steam sterilization activity: Impact on surgical instruments].

Pieragostini R, Franconeri L, Branger G, Quesne C, Berge M, Cauchetier E, Pons JL. Pieragostini R, et al. Ann Pharm Fr. 2019 Jan;77(1):74-84. doi: 10.1016/j.pharma.2018.07.002. Epub 2018 Aug 10. Ann Pharm Fr. 2019. PMID: 30103939 French.

4

Conditional prescriptions of oral antihypertensive drugs for the management of hypertension urgencies in the inpatient setting: An observational study.

Pieragostini R, Perrin G, Nevoret C, Amar L, Jannot AS, Sabatier P, Korb-Savoldelli V, Sabatier B. Pieragostini R, et al. J Clin Pharm Ther. 2020 Apr;45(2):282-289. doi: 10.1111/jcpt.13059. Epub 2019 Sep 28. J Clin Pharm Ther. 2020. PMID: 31562777

5

[Assessment of professional practices on the use of computerized medicine cabinets by registered nurses].

Fere-Gely L, Deville L, Peyron I, Trevisan L, Mackowiak V, Dancoine X, Madelaine I, Touratier S, Pigini S, De Oliveira L, Novacovici P, Le Corre B, Pieragostini R. Fere-Gely L, et al. Among authors: pieragostini r. Ann Pharm Fr. 2024 Sep;82(5):937-943. doi: 10.1016/j.pharma.2024.04.008. Epub 2024 Apr 28. Ann Pharm Fr. 2024. PMID: 38688435 French.

6

Context of instauration and evolution under isavuconazole, a 2-year prospective real-life study.

Pieragostini R, Xhaard A, Sauvageon H, Madelaine I, Touratier S, Denis B. Pieragostini R, et al. Med Mycol. 2023 Apr 3;61(4):myad033. doi: 10.1093/mmy/myad033. Med Mycol. 2023. PMID: 36963767

7

Assessment of the clinical perception, quality of life and satisfaction of patients with severe congenital haemophilia A without inhibitor after 1 year of emicizumab therapy.

Oka G, Roussel-Robert V, Levivien C, Lopez I, Pieragostini R. Oka G, et al. Among authors: pieragostini r. Haemophilia. 2023 May;29(3):709-715. doi: 10.1111/hae.14755. Epub 2023 Feb 7. Haemophilia. 2023. PMID: 36748858 Review.

8

[Assessment of the budgetary impact of an emicizumab therapy introduction for patients with severe haemophilia A without inhibitor].

Oka G, Pieragostini R, Roussel-Robert V, Paubel P, Degrassat-Theas A, Lopez I. Oka G, et al. Among authors: pieragostini r. Ann Pharm Fr. 2023 May;81(3):529-537. doi: 10.1016/j.pharma.2022.11.001. Epub 2022 Nov 12. Ann Pharm Fr. 2023. PMID: 36375527 French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters